ENLIVEN THERAPEUTICS INC (ELVN) Institutional Ownership Changes & 13F Activity
ENLIVEN THERAPEUTICS INC (ELVN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Price T Rowe Associates Inc, Polar Capital Holdings Plc, Venrock Adviser, Llc, Orbimed Advisors Llc, and First Light Asset Management, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +51,824 | +221.1% | 75,265 | $3.82M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +325,077 | +18.6% | 2,068,992 | $105.00M | Q2 2026 | Sep 02, 2026 |
| Allianz Asset Management Gmbh | Buy | +52,008 | — | 52,008 | $2.64M | Q2 2026 | Sep 02, 2026 |
| Optimize Financial Inc | Sell | -52 | -0.3% | 15,003 | $761.40K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +21,401 | +67.1% | 53,315 | $2.71M | Q2 2026 | Aug 24, 2026 |
| Assenagon Asset Management S.A. | Buy | +306,574 | — | 306,574 | $15.56M | Q2 2026 | Aug 21, 2026 |
| Seven Fleet Capital Management Lp | Buy | +201,356 | +122.8% | 365,386 | $18.54M | Q2 2026 | Aug 17, 2026 |
| Capstone Investment Advisors, Llc | Buy | +10,577 | — | 10,577 | $536.78K | Q2 2026 | Aug 17, 2026 |
| Price T Rowe Associates Inc | Buy | +2,806,160 | +2870.8% | 2,903,907 | $147.37M | Q2 2026 | Aug 14, 2026 |
| Polar Capital Holdings Plc | Buy | +1,364,703 | +26.9% | 6,430,636 | $326.35M | Q2 2026 | Aug 14, 2026 |
| Venrock Adviser, Llc | Sell | -1,200,000 | -69.5% | 526,331 | $26.71M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Sell | -1,182,906 | -14.9% | 6,776,632 | $343.91M | Q2 2026 | Aug 14, 2026 |
| First Light Asset Management, Llc | Buy | +1,158,883 | +574.1% | 1,360,750 | $69.06M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +1,083,313 | — | 1,083,313 | $54.98M | Q2 2026 | Aug 14, 2026 |
| Samlyn Capital, Llc | Buy | +912,637 | — | 912,637 | $46.32M | Q2 2026 | Aug 14, 2026 |
| Tri Locum Partners Lp | Buy | +866,716 | — | 866,716 | $43.99M | Q2 2026 | Aug 14, 2026 |
| Bellevue Group Ag | Sell | -830,867 | -35.8% | 1,490,000 | $75.62M | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Buy | +750,000 | +23.1% | 4,000,000 | $203.00M | Q2 2026 | Aug 14, 2026 |
| Rock Springs Capital Management Lp | Sell | -361,875 | -43.8% | 464,625 | $23.58M | Q2 2026 | Aug 14, 2026 |
| Lord, Abbett & Co. Llc | Buy | +330,759 | — | 330,759 | $16.79M | Q2 2026 | Aug 14, 2026 |
| First Turn Management, Llc | Buy | +330,521 | +53.0% | 954,360 | $48.43M | Q2 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +300,891 | — | 300,891 | $15.27M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +297,164 | +95.9% | 607,189 | $30.81M | Q2 2026 | Aug 14, 2026 |
| Novo Holdings A/S | Sell | -280,000 | -21.9% | 1,000,000 | $50.75M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +251,192 | — | 251,192 | $12.75M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +225,000 | — | 225,000 | $11.42M | Q2 2026 | Aug 14, 2026 |
| Blackstone Inc. | Buy | +215,744 | — | 215,744 | $10.95M | Q2 2026 | Aug 14, 2026 |
| Nicholas Investment Partners, Lp | Buy | +208,801 | +114.3% | 391,529 | $19.87M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +199,495 | +176.4% | 312,560 | $15.86M | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Sell | -162,983 | -74.5% | 55,884 | $2.84M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ELVN activity
Which institutional owners are buying ELVN?
Institutional owners buying ELVN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ELVN activity?
"Buy" means an investor increased their reported position in ELVN compared to the prior reporting period. This reflects growing exposure to ENLIVEN THERAPEUTICS INC (ELVN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ELVN increasing?
Institutional interest in ELVN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ELVN Institutional Insights
- ELVN Overview
- ELVN 13F Institutional Holders
- ELVN Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ELVN Insider Trading & SEC Form 4 Activity
- ELVN Articles
- Top Institutional Investor Stock Rankings